{"title":"Comparative Effectiveness of 5-Fluorouracil Dissolving Microneedle Patch vs. 5-Fluorouracil Intralesional Injection for the Treatment of Keloid Scars: A Randomised, Single-Blinded, Split-Scar Study.","authors":"Jeerapond Leelawattanachai, Savita Sittisaksomjai, Wareeporn Disphanurat","doi":"10.1111/wrr.70078","DOIUrl":"10.1111/wrr.70078","url":null,"abstract":"<p><p>Intralesional 5-fluorouracil (5-FU) injections are effective for treating keloid scars but are often associated with pain, hyperpigmentation and ulceration, limiting patient compliance. Dissolving microneedle (DMN) patches offer a novel, minimally invasive and potentially painless alternative for drug delivery. This study aimed to compare the efficacy and safety of 5-FU DMN patches with intralesional 5-FU injections for the treatment of keloid scars. A total of 37 patients were enrolled in this randomised, single-blind clinical trial. Each scar was split in half, with one half treated weekly using 5-FU DMN patches for 12 weeks and the other half receiving monthly intralesional 5-FU injections over the same period. Outcomes were assessed using the Patient and Observer Scar Assessment Scale (POSAS) and scar volume measurements via multispectral imaging at baseline and Weeks 4, 8, 12 and 24. Both treatments significantly improved POSAS scores and reduced keloid volume over time. Intralesional injections resulted in a faster response and significantly greater volume reduction at Week 12 (p = 0.008), but by Week 24, no significant difference in efficacy was observed between the two methods. DMN patches were associated with significantly less pain and better patient comfort. These findings support the use of 5-FU DMN patches as a minimally invasive, patient-friendly alternative to injections for the long-term management of keloid scars.</p>","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 4","pages":"e70078"},"PeriodicalIF":3.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144800425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mary Junak, Parth Khatri, Jocelyn Zajac, Phillip Kubica, Di Yan, Huy Q Dinh, Angela L F Gibson
{"title":"Spatial Transcriptome Analysis Reveals Diverse Human Burn Wound Microenvironment.","authors":"Mary Junak, Parth Khatri, Jocelyn Zajac, Phillip Kubica, Di Yan, Huy Q Dinh, Angela L F Gibson","doi":"10.1111/wrr.70061","DOIUrl":"10.1111/wrr.70061","url":null,"abstract":"<p><p>Histologic analyses of burn tissue are unable to discern reversible injury. Advanced molecular profiling, such as bulk RNA-sequencing, provides more detail; however, these methods lose spatial context. Spatial transcriptomics allows gene transcripts to be mapped to tissue locations, revealing the molecular pathways activated in the burn tissue microenvironment, where the depth of injury guides prognosis. This work demonstrates the capability of spatial transcriptomics to detect spatial gene expression patterns in burn tissue. Specifically, we show that (i) spatially variable expressed genes are distinct across different burn depth regions, which would not be identified with bulk RNA-sequencing, (ii) transcriptionally distinct burn tissue regions are defined by gene signatures associated with diverse cell types and biological pathways, and (iii) these spatial gene signatures are identified in a subset of previously published bulk samples, suggesting their potential application in large-scale and integrated studies. Caveats of this technology in burn tissue are provided to guide future research. This study highlights the promise of spatial transcriptomics to understand the human burn wound microenvironment and identify specific regions with regenerative potential that can be the target of tailored therapeutics, providing an alternative to imprecise excision and skin grafting.</p>","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 4","pages":"e70061"},"PeriodicalIF":3.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Macrophage-Based Cell Therapy Approach Promotes Collagen Deposition in Diabetic Wounds.","authors":"Kiara Boodhoo, Mare Vlok, Mari van de Vyver","doi":"10.1111/wrr.70071","DOIUrl":"10.1111/wrr.70071","url":null,"abstract":"<p><p>Macrophages play a critical role in wound healing. Modulating macrophage activity has thus been identified as a potential strategy to stimulate immune-mediated tissue regeneration. This study utilised endotoxin tolerization as a strategy to dampen cytokine production upon the ex vivo activation of M2 monocytic cells before collecting their secretome for therapeutic application. The M2 derived secretome was harvested from GM-CSF differentiated THP-1 cells followed by IL4-induced M2 polarisation with or without prior endotoxin tolerization. The protein constituents of the secretome were determined and quantified using label free LC-MS/MS analysis and cytokine levels using enzyme-linked immunosorbent assays. The efficacy of the M2 derived secretome (with and without prior tolerization) to stimulate fibroblast activity was assessed in vitro (scratch assay) and in vivo (murine full thickness wound model). In culture, the secretome (regardless of tolerization) stimulated fibroblast migration and increased the release of hydroxyproline, which is an essential requirement for collagen synthesis. Similarly, in full thickness excisional wounds, a single application of the M2 monocytic cell secretory products post wounding significantly increased collagen deposition within the wounded area compared to controls. There was however no difference evident in the healing outcomes between the wounds treated with M2 monocytic cell derived secretome without tolerization and those treated with secretome derived from tolerized M2 monocytic cells. Despite its impact on ECM deposition in the wound bed, the secretome showed no benefit for superficial wound closure and did not improve the overall histology score. Taken together, the data suggest that M2 secretory products pose a risk for excessive scar formation.</p>","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 4","pages":"e70071"},"PeriodicalIF":3.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144745311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kaisa Põhako-Palu, Liis Preem, Kelli Randmäe, Marta Putrinš, Külli Kingo, Tanel Tenson, Karin Kogermann
{"title":"Development of Rapid and Economic In Vitro Assay and Biorelevant Ex Vivo Biofilm Inhibition Wound Model to Test the Antibacterial Efficacy of Wound Dressings.","authors":"Kaisa Põhako-Palu, Liis Preem, Kelli Randmäe, Marta Putrinš, Külli Kingo, Tanel Tenson, Karin Kogermann","doi":"10.1111/wrr.70080","DOIUrl":"10.1111/wrr.70080","url":null,"abstract":"<p><p>Chronic wounds are a major healthcare problem, consuming resources globally and necessitating innovative wound dressing development. All antimicrobial wound dressings must be tested for safety and antibacterial effectiveness prior to patient use. This study aimed to develop a rapid, economical in vitro assay and biorelevant ex vivo wound biofilm model on porcine skin to test the antibacterial efficacy of antimicrobial wound dressings. The methods were validated using five commercially available wound dressings and experimental electrospun (ES) wound dressing containing chloramphenicol in polycaprolactone and polyethylene oxide fibres (PCL/PEO/CAM). An in vitro assay was used to assess the growth inhibition, killing efficacy, and dressing sterility against multiple bacterial strains and inoculum sizes. Ex vivo models using porcine skin were used to evaluate biofilm inhibition with dressings on top of or inside infected wounds. The in vitro assay allowed rapid initial screening, whilst ex vivo models provided more biorelevant conditions for understanding the efficacy in wound-mimicking environments. The assay and model are suitable for rapid evaluation of antimicrobial efficacy before animal studies and clinical trials. Using various commercially available wound dressings alongside novel dressings for validation ensures that the method is broadly applicable. The antibacterial efficacy of commercial antimicrobial wound dressings and experimental ES PCL/PEO/CAM fibre mat was confirmed. This study highlights the importance of using multiple complementary assays and models to comprehensively assess antimicrobial wound dressing materials.</p>","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 4","pages":"e70080"},"PeriodicalIF":3.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12361873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Analgesic Efficacy, Safety and Tolerability of VPX638 Administered Topically to Painful Wounds.","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.1111/wrr.70067","DOIUrl":"https://doi.org/10.1111/wrr.70067","url":null,"abstract":"","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 4","pages":"e70067"},"PeriodicalIF":3.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G Arun Maiya, Anupama Harihar, Grace Maria Joseph, Esha Arora, Praveen Arany, Rene Jean Bensadoun, Nicolette Nadene Houreld, Liisa Laakso
{"title":"Effectiveness of Photobiomodulation and Exercise-Based Rehabilitation on Pain and Functional Recovery in Patients With Rotator Cuff Pathology.","authors":"G Arun Maiya, Anupama Harihar, Grace Maria Joseph, Esha Arora, Praveen Arany, Rene Jean Bensadoun, Nicolette Nadene Houreld, Liisa Laakso","doi":"10.1111/wrr.70043","DOIUrl":"10.1111/wrr.70043","url":null,"abstract":"<p><p>Rotator cuff (RC) pathology encompasses a wide range of conditions, which include bursitis, tendinitis, tendinosis, partial thickness tears and full-thickness tears. To treat painful musculoskeletal problems, low-level laser therapy (LLLT) has been employed as a non-pharmacological alternative. Photobiomodulation (PBM), which uses light-emitting diodes (LEDs) and other photo-emitting devices, is a minimally invasive approach used to treat a wide range of conditions. The purpose of this pre-post study design is to evaluate the effectiveness of PBM and exercise-based rehabilitation on pain and functional recovery in patients with RC pathology. Twenty of the thirty-seven patients who were tested for shoulder disorders and found to have RC pathology were included in the study. The patients' pain levels were measured using the Numerical Pain Rating Scale (NPRS) both at baseline and 6 weeks later. The mean ± standard deviation of NPRS was calculated, data was checked for normal distribution, and the Wilcoxon rank test was conducted to compare the values. Our study showed a statistically significant reduction in pain scores from baseline (7.33 ± 0.79) to 6 weeks (2.50 ± 0.69), p < 0.001 of PBM and exercise-based rehabilitation. The knowledge about the evidence regarding the effectiveness of PBM, along with exercise-based rehabilitation, is critical.</p>","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 3","pages":"e70043"},"PeriodicalIF":3.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Naturally Derived Biomaterial-Based Microneedles With Microenvironment-Response Potential for Diabetic Wound Healing.","authors":"Xu Gong, Zong-Lin Li, Rui-Peng Cai, Zhen Xiang, Yan-Bin Peng, Yan Chen, Ornella Parolini, Yong-Can Huang","doi":"10.1111/wrr.70049","DOIUrl":"10.1111/wrr.70049","url":null,"abstract":"<p><p>Delayed wound healing and non-healing wounds are common in diabetic patients due to the hostile microenvironments and complex pathophysiology of diabetic wounds. Addressing these challenges remains a significant concern for clinicians and researchers. Recently, microneedle technology has emerged as an effective, minimally invasive delivery system for treating diabetic wounds, offering ease of use and efficient drug delivery. Naturally derived biomaterial-based microneedles have demonstrated excellent biocompatibility, degradability, and low toxicity, enhancing the healing process by providing mechanical support and delivering antimicrobial agents, growth factors, and antioxidants. Some microneedles are designed to adapt to the specific microenvironments of diabetic wounds, leading to improved healing outcomes. This review summarises the design and development of naturally derived biomaterial-based microneedles for diabetic wound healing and discusses the mechanisms of action in response to varying diabetic wound conditions. The review also addresses critical considerations for developing microenvironment-response microneedles, highlighting implications for translational medicine. Collectively, interdisciplinary collaboration and technological innovation have advanced the creation of these microenvironment-response microneedles using natural biomaterials, which hold significant potential for improving diabetic wound healing.</p>","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 3","pages":"e70049"},"PeriodicalIF":3.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Correction to \"Current State-Of-Play of the EU Advanced Therapy Medicinal Product (ATMP) Field, With an Emphasis on Belgian Human Cell and Tissue Products\".","authors":"","doi":"10.1111/wrr.70053","DOIUrl":"10.1111/wrr.70053","url":null,"abstract":"","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 3","pages":"e70053"},"PeriodicalIF":3.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144259037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gilbert Verbeken, Lieke Convents, Nicolas Delmotte, Jean-Pierre Draye, Serge Jennes, Alain Vanderkelen, Griet Nijs, Philippe Lewalle, Etienne Baudoux, Olivier Cornu, Ineke Vanlaere, Anne Pierlot, Thomas Rose, Jean-Paul Pirnay
{"title":"Current State-Of-Play of the EU Advanced Therapy Medicinal Product (ATMP) Field, With an Emphasis on Belgian Human Cell and Tissue Products.","authors":"Gilbert Verbeken, Lieke Convents, Nicolas Delmotte, Jean-Pierre Draye, Serge Jennes, Alain Vanderkelen, Griet Nijs, Philippe Lewalle, Etienne Baudoux, Olivier Cornu, Ineke Vanlaere, Anne Pierlot, Thomas Rose, Jean-Paul Pirnay","doi":"10.1111/wrr.70039","DOIUrl":"10.1111/wrr.70039","url":null,"abstract":"<p><p>The late 1980s saw the emergence of experimental therapies based on human cell and tissue products (HCTPs) within academic and hospital settings, several of them wound healing related. In 2008, the European Commission introduced the Regulation on advanced therapy medicinal products (ATMPs), defining many of these HCTPs as ATMPs, and more specifically as somatic cell therapy medicinal products (sCTMPs) or tissue-engineered products (TEPs). In 2013, we predicted that the ATMP regulation would adversely impact Member States' health care systems and would threaten the sustainability of many HCTPs provided by public health institutions. To assess the current ATMP state of play and investigate whether these predictions ultimately came true, we consulted relevant scientific and trade literature and official competent authority reports and surveyed the former Belgian HCTP producers. We found that the ATMP Regulation produced 19 authorised ATMPs, with 16 of them (84.2%) belonging to the gene therapy medicinal product (GTMP) class and only 3 HCTPs (15.8%), 2 TEPs and 1 sCTMP. List prices varied according to the ATMP class, with public health insurances struggling to reimburse ATMPs, especially the exuberantly priced GTMPs. This led to marketing authorization withdrawals, and crowd funding approaches and lotteries to determine who would receive lifesaving treatments. A hospital exemption (HE) scheme was enacted to protect ATMPs not intended for commercial exploitation. Whilst limited financial resources generally hampered HE utilisation by public actors, stringent regulatory policies made it virtually impossible in Belgium, resulting in meaningful HCTPs no longer being available to surgeons and their patients.</p>","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 3","pages":"e70039"},"PeriodicalIF":3.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12104850/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mahdokht Khanamooei, Seyed Mehdi Ghamsari, Shahin Bonakdar, Hossein Aminianfar, Saeed Farzad-Mohajeri, Fatemeh Saadinam, Massoumeh Jabbari Fakhr, Nazanin Samiei, Parisa Asgharpour, Davoud Shams, Sirous Sadeghian Chaleshtori, Mohammad Reza Mokhber Dezfuli, Mohammad Mehdi Dehghan
{"title":"Cell Imprint-Mediated Differentiation of Adipose-Derived Stem Cells Into Keratinocytes Enhances Wound Healing on Collagen-Based Scaffolds: An Ovine Model Study.","authors":"Mahdokht Khanamooei, Seyed Mehdi Ghamsari, Shahin Bonakdar, Hossein Aminianfar, Saeed Farzad-Mohajeri, Fatemeh Saadinam, Massoumeh Jabbari Fakhr, Nazanin Samiei, Parisa Asgharpour, Davoud Shams, Sirous Sadeghian Chaleshtori, Mohammad Reza Mokhber Dezfuli, Mohammad Mehdi Dehghan","doi":"10.1111/wrr.70037","DOIUrl":"10.1111/wrr.70037","url":null,"abstract":"<p><p>Full-thickness skin wound management remains a significant clinical challenge, necessitating innovative approaches that combine cellular therapy with biomaterial scaffolds. One of the promising approaches in regenerative medicine is the recellularisation of wound dressings. A polydimethylsiloxane (PDMS) substrate imprinted with ovine foetal keratinocytes was used as a template to induce the keratinocyte differentiation of adipose-derived mesenchymal stem cells (ADSCs) in this study. The therapeutic efficacy on full-thickness cutaneous wound regeneration was evaluated by employing keratinocyte-differentiated ADSCs (KC-ADSCs) in combination with collagen scaffolds in an ovine model. The successful differentiation of ADSCs into keratinocyte-like cells through the imprinted PDMS substrate was confirmed via immunocytochemical analysis of specific keratinocyte markers. The study implemented a randomised controlled design comparing four treatment groups: KC-ADSCs seeded on a collagen scaffold, undifferentiated ADSCs on a collagen scaffold, acellular collagen scaffold, and untreated controls. Wound healing was evaluated with and without polypropylene wound isolation chambers to prevent keratinocyte migration and wound contraction. Healing outcomes were assessed through standardised macroscopic documentation and comprehensive histopathological analysis over 3 weeks. The KC-ADSC/collagen scaffold combination demonstrated significantly superior wound healing characteristics (p < 0.05), including enhanced re-epithelialisation, advanced granulation tissue maturation, reduced inflammatory infiltrate, and improved neovascularisation compared to control groups. This therapeutic superiority was particularly evident in chambered wounds, where the KC-ADSC/collagen construct promoted substantial epithelial regeneration despite restricted wound contraction and cell migration. Ultimately, this method can be introduced as a growth factor-independent approach for cell differentiation and a clinically applicable therapeutic strategy for skin tissue engineering and regenerative medicine.</p>","PeriodicalId":23864,"journal":{"name":"Wound Repair and Regeneration","volume":"33 3","pages":"e70037"},"PeriodicalIF":3.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}